Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III - V).
about
Drug-Induced Metabolic AcidosisCost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland.Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective.
P2860
Sevelamer carbonate for the treatment of hyperphosphatemia in patients with kidney failure (CKD III - V).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Sevelamer carbonate for the tr ...... kidney failure (CKD III - V).
@en
Sevelamer carbonate for the tr ...... n patients with kidney failure
@nl
type
label
Sevelamer carbonate for the tr ...... kidney failure (CKD III - V).
@en
Sevelamer carbonate for the tr ...... n patients with kidney failure
@nl
prefLabel
Sevelamer carbonate for the tr ...... kidney failure (CKD III - V).
@en
Sevelamer carbonate for the tr ...... n patients with kidney failure
@nl
P2860
P1476
Sevelamer carbonate for the tr ...... kidney failure (CKD III - V).
@en
P2093
Markus Ketteler
Patrick Biggar
P2860
P304
P356
10.1517/14656566.2010.526107
P407
P577
2010-11-01T00:00:00Z